510(k) Report

510(k) · Cleared

Cleared

A1AT Genotyping Test

K171868510(k) TraditionalCleared Nov 11, 2017142-day reviewClass II21 CFR 866.5130

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Progenika Biopharma S.A., A Grifols Company · PZH Serpina1 Variant Detection System

Cleared on Nov 11, 2017 as substantially equivalent to K063498 (Sebia, 2007) after a 142-day review. Its family tree reaches back 1 generation to 2007. 2 later devices descend from it.

Decided
Nov 11, 2017
Review
142 days
Class
Class II
Product code
PZH
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K063498 (2007). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2019: 1 descendant cleared2021: 1 descendant clearedK063498 · Hydragel 18 A1AT Isofocusing Kit (PN 4356) · Sebia · 200720052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant K063498 · Hydragel 18 A1AT Isofocusing Kit (PN 4356) · Sebia · 20070
  1. Root · 1 generation backK063498 Hydragel 18 A1AT Isofocusing Kit (PN 4356)Sebia · 2007
  2. This deviceK171868 A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company · 2017
  3. Descendant · cites it directly · 1 of its ownK192858 A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company · 2019
  4. Descendant · 2 generations on · 0 of its ownK211115 A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company · 2021

Most influential descendants

Showing 2 of 2 · See all
  • K192858A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company · 2019 · cites it directly1descendant
  • K211115A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company · 2021 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K063498Hydragel 18 A1AT Isofocusing Kit (PN 4356)Sebia2007—
0 (this device)K171868A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company2017—
+1K192858A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company2019—
+2K211115A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202110
FIG. 1 — Lineage of K171868, 2007–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PZH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PZH device

  1. #1 K211115 A1AT Genotyping Testscore 1.9 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K063498Hydragel 18 A1AT Isofocusing Kit (PN 4356)
Summary page 5
…e same reagent components are provided in each case). G. Substantial Equivalence Information: Predicate Device: HYDRAGEL 18 A1AT ISOFOCUSING Kit 510(k) number: k063498 Applicant: SEBIA, Inc. Main conclusion: Although technologically different (isoelectrofocusing vs. PCR/hybridization bas…
Sebia2007—

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K192858A1AT Genotyping TestProgenika Biopharma S.A., A Grifols Company20191

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K192858 (Progenika Biopharma S.A., A Grifols Company, 2019) has gone furthest, with 1 descendant of its own.

How does its category compare?

All PZH devices

PZH Serpina1 Variant Detection System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · PZH

1in 2021

2017: 12019: 12021: 1
2007high 1 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PZH

Too few PZH 510(k)s in any year since 2007 to give a median.

Recalls per year · PZH

No recall names PZH since 2007.

Adverse event reports per year · PZH

No MAUDE report names PZH since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20171—00
20180—00
20191—00
20200—00
20211—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Progenika A1AT genotyping kit is a qualitative, polymerase chain reaction (PCR) and hybridization-based in vitro diagnostic test to be used with the Luminex 200TM instrument (with xPONENT® software) for the simultaneous detection and identification of 14 allelic variants and their associated alleles found in the Alpha-1 antitrypsin (A1AT) codifying gene SERPINA1. The test is intended for use with genomic DNA extracted from human whole blood samples…

Read the full statement (118 words)

The Progenika A1AT genotyping kit is a qualitative, polymerase chain reaction (PCR) and hybridization-based in vitro diagnostic test to be used with the Luminex 200TM instrument (with xPONENT® software) for the simultaneous detection and identification of 14 allelic variants and their associated alleles found in the Alpha-1 antitrypsin (A1AT) codifying gene SERPINA1. The test is intended for use with genomic DNA extracted from human whole blood samples collected as dry blood spots (DBS) or in K2-EDTA. The A1AT allelic variant genotypes and associated allele results, when used in conjunction with clinical findings and other laboratory tests, are intended as an aid in the diagnosis of individuals with A1AT deficiency (A1ATD).

The kit is indicated for prescription use only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171868: A1AT Genotyping Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171868

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026